Cerebral Hypoxia Clinical Trial
— BOXOfficial title:
Targeted Cerebral Saturations in Extremely Preterm Infants
Verified date | April 2024 |
Source | Stanford University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Implementing target ranges for regional cerebral saturations in extremely preterm infants in the first week of life may improve neurodevelopmental outcomes at 22-26 months corrected age compared to those without targeted cerebral saturations (Csat) using near-infrared spectroscopy (NIRS). Infants will be randomized to a targeted cerebral saturation monitoring group with visible reading of Csat or to a control group with cerebral saturation monitoring, but with blinded Csat measures. Those in the targeted Csat group will follow a treatment guideline to maintain cerebral oxygenation in the target range. The primary outcome is neurodevelopmental outcome as determined by Bayley III cognitive scale score.
Status | Active, not recruiting |
Enrollment | 100 |
Est. completion date | December 31, 2025 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 2 Days |
Eligibility | Inclusion Criteria: - Very preterm infants with gestational age at least 23 weeks but less than 29 completed weeks - Less than 6 hours of age Exclusion Criteria: - Skin integrity insufficient to allow placement of NIRS sensors - Decision not to provide full intensive care support - Congenital condition, other than premature birth, that adversely affects life expectancy or neurodevelopment |
Country | Name | City | State |
---|---|---|---|
United States | Lucile Packard Children's Hospital Stanford | Palo Alto | California |
Lead Sponsor | Collaborator |
---|---|
Stanford University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Burden of Cerebral hypoxia or hyperoxia | Burden of cerebral hypoxia or hyperoxia from NIRS measures | From birth until first 7 days of life | |
Primary | Neurodevelopmental outcome | Neurodevelopmental outcomes will be assessed using the cognitive component of the Bayley Scales of Infant Development-III at 22-26 months of age. Scores range from 55-145 with higher number representing a better neurodevelopmental outcome. | 22-26 months of age | |
Secondary | Death | Death prior to hospital discharge | from birth until hospital discharge, an average of 3 months. | |
Secondary | Retinopathy of prematurity | Occurrence of retinopathy of prematurity prior to hospital discharge | from birth until hospital discharge, an average of 3 months. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05028023 -
Tracheal Dilatation in Pediatric Patients With Acquired Tracheal Stenosis, and the Effects of Apneic Oxygenation
|
N/A | |
Recruiting |
NCT05048680 -
Effect of Hypoxic Conditioning on Cerebrovascular Health in the Elderly
|
N/A | |
Completed |
NCT03303118 -
The Effects of Hypobaria vs Hypoxia on Cerebral Functions.
|
N/A | |
Recruiting |
NCT02133638 -
Sevoflurane Decreases the Risk of Postoperative Delirium After Cerebral Hypoxemia During Surgery
|
Phase 4 | |
Recruiting |
NCT06320743 -
Cerebral and Peripheral Near Infrared Spectroscopy Monitoring in Low and High Flow Anaesthesia in Pediatric
|
N/A | |
Recruiting |
NCT04971564 -
Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia
|
||
Completed |
NCT01620203 -
Observational Study in Preterm Infants With Intracranial Hemorrhage
|
||
Completed |
NCT03916133 -
Analysis of Selective Cerebrovascular Distribution With FDCT in the Angiosuite
|
N/A | |
Completed |
NCT01432184 -
Feasibility Trial to Maintain Normal Cerebral Oxygen Saturation in High-Risk Cardiac Surgery
|
N/A | |
Completed |
NCT05652426 -
The Effect of Hypoxic and Normoxic Cerebral Oximetry Levels on Cognitive Functions After Carotid Endarterectomy
|
||
Completed |
NCT02605005 -
The Impact of a Beach Chair Position During Shoulder Arthroscopy on Regional Cerebral Oxygen Saturation : Comparison of Interscalene Block and General Anesthesia
|
N/A | |
Completed |
NCT01757561 -
The Difference in Cerebral Oxygenation Between Propofol and Sevoflurane
|
N/A | |
Active, not recruiting |
NCT05171881 -
Brain Oxygenation-II
|
Phase 2 | |
Not yet recruiting |
NCT06316596 -
Brain Oxygenation in Newborns Due to Neuroaksial Methods
|
N/A | |
Completed |
NCT06306950 -
Prioritization of Cerebral Deoxygenation in Severe Traumatic Brain Injury and Mortality Benefit.
|
N/A |